In addition, the Japanese researchers observed that serum A-FABP levels significantly increased by 73% after androgen deprivation therapy in patients with prostate cancer, suggestive of a negative association between androgen and serum A-FABP levels9. The gene discussed is FABP4; the disease is prostate carcinoma.